Molecular determinants of disease severity in urinary tract infection
Open Access
- 15 June 2021
- journal article
- review article
- Published by Springer Nature in Nature Reviews Urology
- Vol. 18 (8) , 468-486
Abstract
The most common and lethal bacterial pathogens have co-evolved with the host. Pathogens are the aggressors, and the host immune system is responsible for the defence. However, immune responses can also become destructive, and excessive innate immune activation is a major cause of infection-associated morbidity, exemplified by symptomatic urinary tract infections (UTIs), which are caused, in part, by excessive innate immune activation. Severe kidney infections (acute pyelonephritis) are a major cause of morbidity and mortality, and painful infections of the urinary bladder (acute cystitis) can become debilitating in susceptible patients. Disease severity is controlled at specific innate immune checkpoints, and a detailed understanding of their functions is crucial for strategies to counter microbial aggression with novel treatment and prevention measures. One approach is the use of bacterial molecules that reprogramme the innate immune system, accelerating or inhibiting disease processes. A very different outcome is asymptomatic bacteriuria, defined by low host immune responsiveness to bacteria with attenuated virulence. This observation provides the rationale for immunomodulation as a new therapeutic tool to deliberately modify host susceptibility, control the host response and avoid severe disease. The power of innate immunity as an arbitrator of health and disease is also highly relevant for emerging pathogens, including the current COVID-19 pandemic.Keywords
This publication has 270 references indexed in Scilit:
- Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin–mediated cellular injuryProceedings of the National Academy of Sciences, 2010
- Daughter cell separation is controlled by cytokinetic ring‐activated cell wall hydrolysisThe EMBO Journal, 2010
- Defining mechanisms that regulate RNA polymerase II transcription in vivoNature, 2009
- Harmful molecular mechanisms in sepsisNature Reviews Immunology, 2008
- Functional mechanics of the ATP-dependent Lon protease- lessons from endogenous protein and synthetic peptide substratesBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2008
- TLR-mediated immune responses in the urinary tractCurrent Opinion in Microbiology, 2008
- TLR4-Initiated and cAMP-Mediated Abrogation of Bacterial Invasion of the BladderCell Host & Microbe, 2007
- Iron metabolism at the host pathogen interface: Lipocalin 2 and the pathogen-associated iroA gene clusterThe International Journal of Biochemistry & Cell Biology, 2007
- How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strainsProceedings of the National Academy of Sciences, 2006
- The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infectionNature Medicine, 2006